Wistar Institute ( Wistar Institute )

Wistar Institute

Wistar Institute's picture

The Wistar Institute is the nation’s first independent institution devoted to medical research and training. The Wistar Institute has evolved from its beginnings as an anatomical teaching museum to its present-day status as an international leader in basic biomedical research.

In 1972, The Wistar Institute was designated a National Cancer Institute Cancer Center in basic research—a distinction it holds to this day.

Wistar discoveries have led to the development of vaccines for rabies, rubella, and rotavirus, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools.

Wistar Institute press release, blog etc

12/21/2017 - 07:22 Wistar Scientists Develop Improved DNA Vaccine Targeting the Tumor Microenvironment
12/19/2017 - 09:42 Novel Combination Therapy Shown to Be Effective in Ovarian
12/14/2017 - 13:43 Wistar Scientists Identify Mechanism of Impaired Dendritic Cell Function that Weakens Immune and Therapeutic Response to Cancer
11/14/2017 - 16:56 Scientists Generate a Comprehensive Collection of Pre-clinical Models for Melanoma Research
11/14/2017 - 05:35 ITUS Corporation Licenses CAR-T Technology from The Wistar Institute
11/13/2017 - 09:54 Scientists Identified a Cellular Network That Short Circuits the Antitumor Effect of Novel Immunotherapy
11/13/2017 - 07:06 Wistar Scientists Identified a Cellular Network That Short Circuits the Antitumor Effect of Novel Immunotherapy
11/06/2017 - 10:09 The Wistar Institute Awarded More Than $16.5M in Grants to Fund Cancer & Infectious Disease Research and Training
11/02/2017 - 06:51 Wistar Expands Collaboration & Signs Exclusive License Agreement with Mans Best Friend Therapeutics to Develop Novel Veterinary Vaccine Technology
10/31/2017 - 07:34 Major Report Sets Out How to Accelerate Cancer Research and Care, Delivering on US Cancer Moonshot Initiative
10/05/2017 - 06:22 NIH Selects Wistar Scientist Kavitha Sarma, Ph.D., for New Innovator Award
10/05/2017 - 05:44 DNA-based Zika Vaccine Candidate is Safe and Effective at Inducing Immune Response
09/27/2017 - 08:44 Melanoma Cells Rewire Their Signaling Pathways to Resist Drug Treatment
09/26/2017 - 07:53 Study Investigates Novel Immunotherapeutic Delivery Strategy for Preventing Infection with Antibiotic Resistant Bacteria
09/20/2017 - 10:06 Characterization of a Slowly Proliferating Population of Melanoma Cells with High Metastatic Properties
09/19/2017 - 12:18 Tumor-infiltrating B Lymphocytes Promote Melanoma Progression and Resistance to Therapy
09/11/2017 - 16:46 A Newly Identified Mitochondrial Metastasis Suppressor Pathway Controls Metabolic Reprogramming of Tumor Cells
09/11/2017 - 10:27 Modulating T-Cell Metabolism Uncovers New Technology for Enhancing Immunotherapy